Brooks O'Neil
Stock Analyst at Lake Street
(0.59)
# 4,127
Out of 5,097 analysts
34
Total ratings
26.47%
Success rate
-20.71%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFMD LifeMD | Maintains: Buy | $14 → $8 | $3.20 | +150.00% | 4 | Nov 18, 2025 | |
| TNDM Tandem Diabetes Care | Downgrades: Hold | $75 → $12 | $23.26 | -48.41% | 2 | Aug 11, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $14 → $8 | $3.43 | +133.24% | 7 | Aug 11, 2025 | |
| PIII P3 Health Partners | Maintains: Buy | $50 → $20 | $3.61 | +454.02% | 2 | Apr 21, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $84.51 | +30.16% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $31.69 | -5.33% | 1 | Feb 24, 2025 | |
| SMLR Semler Scientific | Maintains: Buy | $40 → $71 | $17.41 | +307.81% | 1 | Jan 24, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $5.99 | +334.06% | 1 | Dec 19, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $49.38 | +11.38% | 3 | Oct 4, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $32 → $18 | $20.70 | -13.04% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $20 | $9.00 | +122.22% | 1 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $5.71 | -12.43% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $7.04 | +70.45% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $27.82 | -6.54% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $0.35 | +3,086.56% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $31.02 | +311.03% | 1 | Sep 15, 2020 |
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $3.20
Upside: +150.00%
Tandem Diabetes Care
Aug 11, 2025
Downgrades: Hold
Price Target: $75 → $12
Current: $23.26
Upside: -48.41%
AVITA Medical
Aug 11, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $3.43
Upside: +133.24%
P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50 → $20
Current: $3.61
Upside: +454.02%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $84.51
Upside: +30.16%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $31.69
Upside: -5.33%
Semler Scientific
Jan 24, 2025
Maintains: Buy
Price Target: $40 → $71
Current: $17.41
Upside: +307.81%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $5.99
Upside: +334.06%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $49.38
Upside: +11.38%
Alphatec Holdings
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $20.70
Upside: -13.04%
Aug 9, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $9.00
Upside: +122.22%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $5.71
Upside: -12.43%
Mar 7, 2024
Initiates: Buy
Price Target: $12
Current: $7.04
Upside: +70.45%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $27.82
Upside: -6.54%
Apr 8, 2022
Initiates: Buy
Price Target: $11
Current: $0.35
Upside: +3,086.56%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $31.02
Upside: +311.03%